News

The company is expanding to other Asian markets starting this year.

The company is now offering a topical Finasteride and Minoxidil spray as well as oral spironolactone through its virtual care platform. 

The startup leverages blockchain and FHIR technologies to allow for secure data exchange between healthcare organizations.

The class action lawsuit alleges a proxy statement provided to investors before the merger misrepresented the company's financial performance and prospects.

Over 100 clinics have already joined WellAway since the company received its license last year.

Patients can use the service to access support groups, navigation tools and a clinical trial-matching program. 

Also: AI-enabled documentation tool DeepScribe raises $30 million, cancer risk stratification platform PreciseDx scores $10.75 million and care navigation startup HeyRenee brought in $4.4 million.

The company also unveiled its 2021 revenue. 

Health tech companies raised nearly $40 billion last year, according to Silicon Valley Bank's Healthcare Investments and Exits Report. IPOs were also up, but those companies didn't fare as well in the public markets.

Also, Tech accelerator calls for gut health startups in the EMEA region